Enzo Biochem, Inc. (ENZ)
| Market Cap | 115.93M |
| Revenue (ttm) | 118.18M |
| Net Income (ttm) | 300,000 |
| Shares Out | 48.71M |
| EPS (ttm) | 0.01 |
| PE Ratio | 396.67 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 49,990 |
| Open | 2.39 |
| Previous Close | 2.35 |
| Day's Range | 2.37 - 2.45 |
| 52-Week Range | 2.23 - 4.15 |
| Beta | 0.78 |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | Jun 8, 2022 |
About ENZ
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides...
Financial Performance
Financial StatementsNews
Enzo Biochem Adjourns Annual Meeting of Shareholders to Complete Vote on Proposal
Meeting Scheduled for April 8, 2022 at 9:00 AM ET
Enzo Biochem Adjourns Annual Meeting of Shareholders Until April 8, 2022
NEW YORK, NY, April 01, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced its 2021 Annual Meeting of Share...
Enzo Biochem Appoints David Bench and Kara Cannon to New Executive Management Positions
NEW YORK, NY, March 28, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced two key appointments to its new ...
Enzo Biochem Reports Second Quarter Fiscal 2022 Result and Provides Leadership and Corporate Updates
Conference call and live webcast scheduled for today, Monday, March 14, 2022 at 4:30 pm (ET)
Enzo Biochem to Present at the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum
NEW YORK, NY, March 10, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ), a leading biosciences and diagnostics company, today announced that management will present at the KeyBanc Capital Market...
Enzo Biochem to Report Second Quarter 2022 Financial Results and Business Update on Monday, March 14th
Conference Call and Webcast Scheduled for March 14, 2022, 4:30 pm ET
Hamid Erfanian and Bradley Radoff Appointed to Enzo Biochem's Board of Directors
NEW YORK, NY, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the appointments of Hamid Erfania...
Enzo Biochem Reports First Quarter 2022 Financial Results and Provides Business Update
Conference call and live webcast scheduled for today, Wednesday, December 15, 2021 at 4:30 pm (ET)
Enzo Biochem to Report First Quarter 2022 Financial Results and Business Update on Wednesday, December 15th
Conference Call and Webcast Scheduled for December 15, 2021, 4:30 pm ET
ENZO BIOCHEM REPORTS INDUCEMENT AWARDS TO NEW CHIEF EXECUTIVE OFFICER
NEW YORK, NY, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, announced today that on November 8, 2021, it grant...
Bradley L. Radoff Issues Letter to the Independent Directors of Enzo Biochem Regarding Their Unwillingness to Acknowl...
HOUSTON--(BUSINESS WIRE)--Bradley L. Radoff, who together with his affiliates holds approximately 7.5% of the outstanding common shares of Enzo Biochem, Inc. (NYSE: ENZ) ("Enzo" or the "Company"), today...
Enzo Biochem Expands GoTestMeNow™ Online Portal to Provide Patients with Direct Access to Private Testing for Sexuall...
GoTestMeNow™ enables individuals to instantly and privately access physician-authorized testing for a broad range of STIs including chlamydia, gonorrhea, syphilis, HIV-1/2, hepatitis and herpes
Bradley L. Radoff Issues Open Letter to Recently-Appointed Independent Directors of Enzo Biochem
HOUSTON--(BUSINESS WIRE)--Bradley L. Radoff, who together with his affiliates holds approximately 7.2% of the outstanding common shares of Enzo Biochem, Inc. (NYSE: ENZ) ("Enzo" or the "Company"), today...
HAMID ERFANAIN NAMED CHIEF EXECUTIVE OFFICER OF ENZO BIOCHEM TO ACCELERATE EXPANSION AND COMMERCIALIZATION OF KEY DIA...
Dr. Elazar Rabbani to remain Chairperson of the Board and will assume new role as Chief Scientific Officer
Enzo Biochem Clocks 27% Revenue Growth In Q4, Margin Remains Stable
Biosciences and diagnostics company Enzo Biochem Inc (NYSE: ENZ) reported fourth-quarter FY21 revenue growth of 27% year-on-year to $24.8 million. Revenue decreased 24% sequentially.
Enzo Biochem Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Update
Conference call and live webcast scheduled for today, Tuesday, October 12, 2021 at 8:30 am (ET)
Enzo Biochem to Report Fourth Quarter and Full Year 2021 Financial Results and Business Update on Tuesday, October 12th
Conference Call and Webcast Scheduled for October 12, 2021, 8:30 am ET
FDA Expands EUA For Rapid Extraction On One COVID-19 Test System
Enzo Biochem Inc (NYSE:ENZ) has received an expansion of its FDA Emergency Use Authorization (EUA) for its rapid extraction method on its Ampiprobe SARS-CoV-2 Test System to detect SARS-CoV-2, including...
Enzo Biochem Announces Online Service with TrustAssure to Schedule Timely PCR Testing Required for International Travel
Testing will be available through CLX Health's TrustAssure™ Global Testing Platform for international travelers from New York and New Jersey who will need to complete testing immediately prior to travel.
Enzo Biochem Reports Third Quarter Fiscal 2021 Results
Conference call and live webcast scheduled for today, Wednesday, June 9, 2021 at 4:30 PM (ET).
Enzo Biochem to Report Third Quarter 2021 Financial Results on Wednesday, June 9
Conference Call and Webcast Scheduled for June 9, 2021, 4:30 pm ET Conference Call and Webcast Scheduled for June 9, 2021, 4:30 pm ET
Enzo's Universal AMPICOLLECT™ Used on GENFLEX® Molecular Platform Cleared for Distribution by FDA Under Emergency Use...
Company's specimen collection kit now available for use in COVID-19 testing in the U.S.
Enzo Biochem Reports Second Quarter Fiscal 2021 Results; Company Provides Leadership and Corporate Updates
Conference call and live webcast scheduled for today, Monday, March 15, 2021 at 4:30 pm (ET)
Enzo Biochem to Participate in the H.C. Wainwright Global Life Sciences Conference
NEW YORK, NY, March 04, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced that the Company will present at ...
Enzo Biochem to Report Second Quarter 2021 Financial Results on Monday, March 15
Conference Call and Webcast Scheduled for March 15, 2021, 4:30 pm ET Conference Call and Webcast Scheduled for March 15, 2021, 4:30 pm ET